Evidence map›Paper›PMID 33302597›Full record

ArticleAntibiotics (Basel, Switzerland)2020

The Short Lipopeptides (C

Kirsten Reddersen, Katarzyna E Greber, Izabela Korona-Glowniak, Cornelia Wiegand

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Kirsten ReddersenKlinik für Hautkrankheiten, Universitätsklinikum Jena, 07743 Jena, Germany.ORCID 0000-0001-9814-6419
Katarzyna E GreberPhysical Chemistry Department, Faculty of Pharmacy, Medical University of Gdansk, 80-416 Gdansk, Poland.
Izabela Korona-GlowniakDepartment of Pharmaceutical Microbiology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0003-1634-0387
Cornelia WiegandKlinik für Hautkrankheiten, Universitätsklinikum Jena, 07743 Jena, Germany.
Klinik und Poliklinik für Hautkrankheiten · DEGdańsk Medical University · PLMedical University of Lublin · PL

Funding

German Research Foundation and Open Access Publication Fund of the Thueringer Universitaets- und Landesbibliothek Jena 433052568
6 · The paper itself

Abstract

The search for new antimicrobial strategies is of major importance since there is a growing resistance of both bacteria and fungi to existing antimicrobials. Lipopeptides are promising and potent antimicrobial compounds. For translation into clinically useful molecules, effectiveness of peptide treatment against human infections must be proved in complex in vitro wound models. The aim of this study was to examine if the synthesized short lipopeptides (C

Indexed as

cell protectioncoculture modelHaCaT keratinocytesin vitro infection modelshort synthetic antimicrobial lipopeptidesStaphylococcus aureus

Identifiers

PMID33302597
PMCPMC7764661
OpenAlexW3111195563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.